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Purpose: To stratify complications of percutaneous nephrolithotomy (PCNL) in a sin-
gle, tertiary hospital by use of the modified Clavien system.
Materials and Methods: From May 1987 to December 2010, 1,236 cases of PCNL were 
performed at our institute. Medical records were available for 826 cases of PCNL from 
698 patients, from February 1995 to December 2010. Using multiple factors, we retro-
spectively reviewed and analyzed 698 patients for complication rates classified by the 
modified Clavien grading system, along with success rates.
Results: In 698 patients, staghorn stone patients accounted for 33.8% (236 patients). 
Initial and overall stone-free rates were 69.9% and 88.8%. A total of 297 complications 
were documented in 282 patients. According to the modified Clavien classification, 
grade I, II, IIIa, IIIb, IVa, IVb, and V complications were observed in 88 (12.6%), 145 
(20.8%), 31 (4.4%), 5 (0.7%), 6 (0.9%), 4 (0.6%), and 3 (0.4%) patients, respectively. 
Transient peri-nephrostomy catheter urine leakage (15.2%) was the most common com-
plication, followed by transient fever ＞38
o (11%) and transfusion (6.9%). Other in-
dividual complications occurred in less than 1.5% of cases. In patients with staghorn 
stones, grade I, II, IIIb, and IVa complications were significantly more common, and 
all grade IVb and V complications occurred in patients with staghorn stones.
Conclusions: The modified Clavien classification provides a standardized grading sys-
tem for complications of PCNL, although consensus on specific complications would 
prompt better comparison between centers. A shorter operation time is imperative to 
achieve less bleeding. Previous stone-related fever and staghorn stones are significant 
contributing factors for developing postoperative fever.
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INTRODUCTION
Numerous procedures are now available for the manage-
ment of urinary stones. For the management of upper uri-
nary calculi, the method of dilating the tract after percuta-
neous renal puncture to specifically remove urinary calculi 
was first established in 1976 by Fernström and Johansson 
[1]. Advances in surgical technique and equipment have 
further contributed to percutaneous nephrolithotomy 
(PCNL) becoming the recommended primary treatment 
option for most patients with large-volume renal and stag-
horn calculi [2]. 
The outcomes of PCNL can be interpreted in terms of suc-
cess and complication rates. “Success” is often defined as 
the absence of residual stone fragments under conven-
tional X-ray or computed tomography (CT) or when clin-
ically insignificant residual fragments (CIRF) are 
observed. Although large-series PCNL results have been 
reported in the literature, standardized evaluation of 
“complications” is lacking. Recent attempts to report com-Korean J Urol 2011;52:769-775
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TABLE 1. Patient characteristics
          Variables
No. of patients
Mean age±SD (range)
Mean follow-up (days)±SD 
  (d, range)
Male:female (%)
Stone location (%)
    Staghorn stone
    Renal pelvis
    Renal calyx
    Ureter
Mean stone burden±SD
a 
  (range)
BMI±SD (range)
Laterality
    Right (%)
    Left (%)
    Bilateral stone (%)
Preop pyuria (%)
Preop hematuria (%)
Previous stone history 
  irrelevant to present stone (%)
Stone-related fever (%)
Prior ESWL (%)
698
50.1±14.6 (1-87)
164±280 (1-1,699)
433:265 (62:38)
236 (33.8)
150 (21.5)
201 (28.8)
111 (15.9)
885.1±1,256.3 mm
2 
(16-14,833)
24.3±3.5 (14.7-43.7)
310 (44.4)
327 (46.8)
61 (8.7)
388 (55.6)
357 (51.1)
128 (18.3)
28 (4.0)
244 (35.0)
BMI: body mass index, ESWL: extracorporeal shock wave litho-
tripsy, 
a: Surface area (length x height)
TABLE 2. Classification of surgical complications according to 
the modified clavien grading system
Grade I
Grade II
Grade III
Grade IIIa
Grade IIIb
Grade IV
Grade IVa
Grade IVb
Grade V
Any deviation from the normal postoperative 
course without the need for pharmacological 
treatment or surgical, endoscopic, and radio-
logical interventions. Allowed therapeutic regi-
mens are as follows: drugs as antiemetics, anti-
pyretics, analgetics, diuretics, electrolytes, and 
physiotherapy. This grade also includes wound 
infections opened at the bedside. 
Requiring pharmacological treatment with drugs 
other than such allowed for grade I complica-
tions. Blood transfusions and total parenteral 
nutrition are also included.
Requiring surgical, endoscopic, or radiological in-
tervention
Intervention not under general anesthesia
Intervention under general anesthesia
Life-threatening complication requiring IC/ICU 
management
Single organ dysfunction (including dialysis)
Multiorgan dysfunction
Death of a patient
IC: intermediate care, ICU: intensive care unit
plication rates of PCNL have focused on stratifying them 
by severity by use of the Clavien grading system. First pro-
posed in 1992 and modified in 2004, the modified Clavien 
grading system has been validated in a cohort of 6,336 pa-
tients [3,4]. 
In this article, we retrospectively reviewed our experi-
ence with PCNL to grade perioperative complications ac-
cording to the modified Clavien classification.
MATERIALS AND METHODS
From May 1987 to December 2010, 1,236 cases of PCNL 
from 1,066 patients were performed in our center. Among 
these patients, medical records were available from 
February 1995 to December 2010. In this study, we retro-
spectively reviewed and analyzed 826 cases of PCNL from 
698 patients, after the first 410 cases of PCNLs had already 
been performed. The stone was classified as a staghorn 
stone if a renal pelvic stone had calyceal branching into the 
major calyx [5]. Owing to the tertiary hospital setting of our 
center, numerous patients were referred from other hospi-
tals, and 35% of patients had undergone prior ex-
tracorporeal shock wave lithotripsy therapy and 34% of pa-
tients were diagnosed as having staghorn stones. The pa-
tients’ characteristics are further described in Table 1.
All patients underwent preoperative laboratory exams, 
including blood tests and urinalysis. All patients also un-
derwent simple X-ray of the kidney-ureter-bladder, along 
with CT or intravenous urography. Once the operation day 
was chosen, third-generation oral cephalosporin or quino-
lone was administered for more than 5 days to prevent post-
operative sepsis, if pyuria was present in the urinalysis. 
With the patient under general endotracheal anes-
thesia, a 5 to 6 Fr occlusion balloon catheter was inserted 
in the ipsilateral ureter, which later allowed for injection 
of contrast material for opacification and distension of the 
collecting system to aid in making an appropriate 
puncture. After ureteral catheterization, the patient’s po-
sition was changed to the prone position on a C-arm com-
patible table. Once access was gained with a sheathed nee-
dle, the stylet was removed and a guidewire was inserted, 
through which tract dilatation was performed with either 
an Amplatz dilator or a dilating balloon catheter (Cook 
Urological Inc., Indianapolis, IN, USA). Using a rigid neph-
roscope, stone fragmentation using ballistic or ultrasonic 
devices was done and the stone was evacuated by using 
forceps. Although some question the need for a neph-
rostomy catheter, it was routinely inserted for tamponade 
of bleeding and urine drainage in our center [6,7]. 
The success rate was defined as the absence of residual 
stone fragments under conventional X-ray or CT or when 
CIRF was observed. CIRF was defined as residual frag-
ments that were smaller than 4 mm, asymptomatic, non-
obstructive, and noninfectious [8]. Success was further 
classified as the initial stone-free rate, which was eval-
uated immediately after a single PCNL procedure, and the 
overall stone-free rate, which was evaluated 3 months after 
the initial PCNL and further ancillary procedure had been 
performed.Korean J Urol 2011;52:769-775
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TABLE 3. Peri- and postoperative data
Mean operation time±SD
  (min, range)
Puncture site
    Upper (%)
    Mid (%)
    Lower (%)
Multi-puncture (%)
Supracostal puncture (%)
Simultaneous bilateral PCNL (%)
Balloon dilatation (%)
Intraoperative double J
  catheterization (%)
Urologic Co-operation
    Diverticulectomy (%)
    Endopyelotomy (%)
    Ipsilateral URSL (%)
    Infundibulotomy (%)
Success rate (%)
a
    Initial stone free rate (%)
    Overall stone free rate (%)
Mean hospital stay±SD (d, range)
Mean nephrostomy duration±SD 
  (d, range)
Ancillary procedures (%)
    Re-PCNL (%)
    ESWL (%)
    URSL (%)
Drop in Hb (preop-postop)±SD 
  (g/dl, range)
Increase in Cr (postop-preop)±SD 
  (mg/dl, range)
132.6±61.4 (35-540)
121 (17.3)
268 (38.4)
426 (61.0)
133 (19.1)
117 (16.8)
53 (7.6)
192 (27.5)
279 (40.0)
36 (5.2)
25 (3.6)
21 (3.0)
  3 (0.4)
488 (69.9)
620 (88.8)
4.5±2.6 (0-28)
5.7±5.8 (0-61)
187 (26.8)
  75 (10.7)
111 (15.9)
  3 (0.4)
1.2±1.4 (-2.9-7.5)
0.002±0.189 
(-0.85-1.05)
PCNL: percutaneous nephrolithotomy, URSL: ureterorenosco-
pic lithotripsy, ESWL: extracorporeal shock wave lithotripsy, 
Hb: hemoglobin, Cr: creatinine, 
a: Based on simple X-ray
TABLE 4. Complications
Grade I
    Transient fever ＞38 (atelectasis etc) (%)
    Transient pleural effusion or atelectasis 
      without fever (%)
    Transient elevation of creatinine 
      ＞0.5 (%)
Grade II
    Peri-nephrostomy catheter urine leakage 
      ＜24 h (%)
    Blood transfusion (%)
    Pneumonia (%)
Grade IIIa
    Renal hemorrhage requiring 
      angioembolization (%)
    Postoperative double-J stent placement 
      for urine leakage (%)
    Hemo/pneumothorax requiring chest 
      tube insertion (%)
    Retention due to blood clots (%)
    Nephrostomy catheter dislodgement 
      requiring repositioning (%)
Grade IIIb
    Collecting system perforation (%)
    Infundibular stricture (%)
    Urethral stricture (%)
Grade IVa
    Bowel injury (%)
    Nephrectomy (%)
Grade IVb
    Sepsis (%)
Grade V
90 complications/ 
88 (12.6%) patients
  77 (11.0)
  8 (1.1)
  5 (0.7)
156 complications/ 
145 (20.8%) patients
106 (15.2)
48 (6.9)
  2 (0.3)
32 complications/ 
31 (4.4%) patients
10 (1.4)
  8 (1.1)
  8 (1.1)
  5 (0.7)
  1 (0.1)
5 complications/ 
5 (0.7%) patients
  3 (0.4)
  1 (0.1)
  1 (0.1)
7 complications/ 
6 (0.9%) patients
  5 (0.7)
  2 (0.3)
4 complications/ 
4 (0.6%) patients
  4 (0.6)
3 complications/ 
3 (0.4%) patients
Perioperative complications were classified by using the 
modified Clavien system, which was stratified into five 
grades (Table 2). Past medical history such as hypertension 
(n=221), diabetes (n=105), pulmonary tuberculosis (n=30), 
cerebrovascular accident (n=21), and skeletal abnormal-
ities (n=12) were included as variables. Urologic anatomi-
cal factors such as diverticular stone (n=42), ureteropelvic 
junction obstruction (n=25), single kidney (n=13), mega-
ureter (n=9), duplicated ureter (n=5), horseshoe kidney 
(n=4), and infundibular stricture (n=3) were also entered 
as variables. A p-value ＜0.05 in the multivariate logistic 
regression analysis was considered significant. Odds ra-
tios (ORs) and 95% confidence intervals (CIs) are pre-
sented. All analyses were performed by using the SAS 
System for Windows ver. 9.1 (SAS Institute Inc, Cary, NC, 
USA).
RESULTS
Perioperative data are listed in Table 3. The initial 
stone-free rate was 69.9% (488 patients), and the overall 
stone-free rate was 88.8% (620 patients). The mean hospi-
tal stay was 4.5±2.6 days after the operation. The lowest 
initial success rate was observed in the staghorn stone 
group (46%, p＜0.0089). Furthermore, mean operation 
time (157.91±76.85 days, p＜0.0037) and hospital stay 
(5.18±3.12 days, p＜0.0095) were significantly longer in 
the staghorn stone group. 
Table 4 lists postoperative complications classified by 
the modified Clavien grading system. A total of 297 compli-
cations were documented. Grade I complications were re-
corded in 88 (12.6%), grade II in 145 (20.8%), grade IIIa in 
31 (4.4%), grade IIIb in 5 (0.7%), grade IVa in 6 (0.9%), grade 
IVb in 4 (0.6%), and grade V in 3 (0.4%) patients. 
Transient peri-nephrostomy catheter urine leakage for 
less than 24 hours, requiring only simple dressing, was ob-
served in 106 (15.2%) patients. Fever, defined as at least 
a single episode spiking more than 38°C, was the next com-
mon complication (77 patients, 11.0%). Transfusion was Korean J Urol 2011;52:769-775
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TABLE 5. Comparison of complications between staghorn stone patients and others as stratified by the modified clavien system
Grade
Total 
(n=698) (%)
Staghorn stone
(n=236) (%)
Others
(n=462) (%)
p-value OR 95% CI
I
II
IIIa
IIIb
IVa
IVb
V
  88 (12.6)
145 (20.8)
31 (4.4)
  5 (0.7)
  6 (0.9)
  4 (0.6)
  3 (0.4)
47 (19.9)
66 (28.0)
12 (5.1)
2 (0.8)
5 (2.1)
4 (1.7)
3 (1.3)
41 (8.9)
  79 (11.3)
19 (4.1)
  3 (0.6)
  1 (0.2)
0
0
＜0.0001
0.0013
0.0723
0.0035
0.0060
NA
NA
    2.28
    1.79
    1.77
  5.6
18.3
NA
NA
1.64-3.16
1.26-2.55
0.95-3.23
  1.76-17.76
      2.3-144.95
NA
NA
OR: odds ratio, CI: confidence interval, NA: not applicable
TABLE 6. Multivariate determinants for postoperative fever ＞38
o and bleeding requiring transfusion
Fever Bleeding requiring transfusion
OR 95% CI p-value OR 95% CI p-value
Gender
Age
BMI
Bilateral stone
Prior ESWL
Preop pyuria
Preop hematuria
Previous stone Hx
Stone related fever
Hypertension
Diabetes
Cerebrovascular accident
Pulmonary tuberculosis 
Skeletal abnormalities
Single kidney
Horseshoe kidney
Duplicated ureter
Megaureter
Endopyelotomy 
Diverticulectomy
Ipsilateral URSL
Infundibulotomy
Puncture site
    Upper
    Mid
    Lower
Multi-puncture
Supracostal puncture
Simultaneous bilateral PCNL
Balloon dilatation
Mean OP time
Staghorn stone
0.993
1.810
0.949
6.219
1.037
1.375
0.917
0.887
8.513
0.722
0.870
2.425
0.476
NA
NA
NA
1.113
NA
NA
NA
0.571
NA
0.760
0.499
0.522
1.754
1.679
0.128
0.939
0.999
6.043
0.864, 3.791
0.969, 1.017
0.862, 1.045
  0.572, 67.622
0.494, 2.175
0.547, 3.455
0.626, 1.344
0.333, 2.363
  2.819, 25.710
0.338, 1.542
0.364, 2.077
  0.510, 11.524
0.036, 6.255
NA
NA
NA
0.797, 1.555
NA
NA
NA
0.054, 6.055
NA
0.192, 3.016
0.135, 1.848
0.135, 2.026
0.368, 8.364
0.525, 5.370
0.007, 2.256
0.444, 1.985
0.993, 1.005
  2.581, 14.149
0.1158
0.5576
0.2846
0.1333
0.9242
0.4988
0.6563
0.8099
＜0.0001
0.4003
0.7533
0.2654
0.5724
NA
NA
NA
0.5294
NA
NA
NA
0.6420
NA
0.6969
0.2980
0.3478
0.4809
0.3822
0.1603
0.8698
0.7304
＜0.0001
1.437
1.020
0.968
NA
0.190
4.027
1.944
1.543
NA
0.888
0.593
3.805
NA
NA
NA
NA
1.290
NA
NA
NA
NA
NA
1.730
1.367
0.513
4.244
0.593
NA
1.957
1.009
1.707
0.422, 4.890
0.975, 1.066
0.838, 1.118
NA
0.036, 1.001
  0.429, 37.803
0.846, 4.471
0.312, 7.640
NA
0.262, 3.013
0.134, 2.616
  0.348, 41.575
NA
NA
NA
NA
0.888, 1.873
NA
NA
NA
NA
NA
  0.294, 10.175
0.327, 5.712
0.094, 2.787
  0.638, 28.249
0.096, 3.646
NA
0.555, 6.896
1.001, 1.018
0.403, 7.228
0.5621
0.3870
0.6581
NA
0.0502
0.2228
0.1176
0.5946
NA
0.8486
0.4897
0.2734
NA
NA
NA
NA
0.1814
NA
NA
NA
NA
NA
0.5445
0.6682
0.4394
0.1350
0.5725
NA
0.2960
0.0313
0.4677
OR: odds ratio, CI: confidence interval, BMI: body mass index, NA: not applicable, URSL: Ureterorenoscopic lithootripsy, ESWL: ex-
tracorporeal shock wave lithotripsy, PCNL: percutuneous nephrolithotomy, OP: operation
required in 48 patients (6.9%). Other individual complica-
tions accounted for less than 1.5%. Comparison of compli-
cations between staghorn stone patients and others are 
outlined in Table 5. Grade I, II, IIIb, and IVa complications 
were significantly more common in the staghorn stone 
group. All grade IVb and V complications occurred in stag-
horn stone patients.
All four patients who developed postoperative sepsis 
were staghorn stone patients. All four patients had both 
pyuria and hematuria in preoperative urinalysis, and thus Korean J Urol 2011;52:769-775
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preoperative oral antibiotics were given for more than 5 
days. None of these patients were febrile before the 
operation.
Three patients with staghorn stones died after PCNL. Of 
the two patients who died of septic shock, one eventually 
developed brain edema after continuous renal replace-
ment therapy. The other patient who died of septic shock 
had a history of Parkinson’s disease and eventually devel-
oped stress-induced cardiomyopathy. One patient died 
from hypoxemia and respiratory acidosis caused by pulmo-
nary embolism despite mechanical ventilation. 
To identify determinants of each complication, multi-
variate analysis was performed. Prior stone-related fever 
and staghorn stones were found to be significant con-
tributing factors for postoperative fever ＞38
oC. Mean op-
eration time was found to be significant for bleeding requir-
ing transfusion (Table 6). For other objective complications 
(embolization, chest tube insertion, collecting system per-
foration, bowel injury, nephrectomy, sepsis, death), deter-
minants could not be identified because of the small num-
ber of cases. To identify risk factors for developing compli-
cations classified as grade IIIa or greater according to the 
Clavien system, multivariate logistic regression analysis 
was performed by using the same variables. Only operation 
time was considered a significant contributing factor in the 
univariate analysis (OR, 0.994; 95% CI, 0.989-0.999; 
p=0.0255), but it failed to remain a significant factor in the 
multivariate analysis (OR, 0.993; 95% CI, 0.984-1.000; 
p=0.1071).
DISCUSSION
Percutaneous nephrolithotomy is an established techni-
que used to treat large and complex renal calculi [9]. The 
2005 American Urological Association (AUA) and 2008 
European Association of Urology (EAU) guidelines on the 
management of staghorn calculi recommend PCNL as the 
first-line treatment for staghorn calculi, any renal stone 
that exceeds 20 mm in diameter, and lower calyceal stones 
[2,10].
In Korea, the first PCNL was performed in July 1984 by 
Koh et al [11]. Since May 1987, our center has begun to treat 
calculi of the upper urinary tract by use of the PCNL 
technique. In the first 50 cases, the complication rate 
reached 53.1%, compared with 20% after the initial 50 
patients. At that time, we attributed the complication rates 
mainly to inexperience and improper technique [12]. 
The most recent Korean report of PCNL performed in 
single large center was published in 2009 by Kwon et al [13]. 
In their retrospective report comprising 610 patients, the 
initial stone-free rate was 57.6% and the overall stone-free 
rate was 84.9%. In our center, these were 69.9% and 88.8%, 
respectively. Transfusion was required in 8.7% of patients, 
similar to the 6.9% in our study. Chest tube insertion for 
thoracic complications was necessary in 1.1% of cases, 
which was the same as in our study. Bleeding requiring em-
bolization occurred in 0.8% and sepsis occurred in 1.0% (vs. 
1.4% and 0.6% in our study). 
Reporting a surgical outcome requires not only success 
rates, but also complication rates. Success rates in PCNL 
are easily defined and most articles use the concept of CIRF 
to define success. However, defining complications is diffi-
cult, and without a standardized method of classifying 
them, comparing complication rates in one study with 
those in another may be problematic, especially when cer-
tain factors are not classified as complications, such as fe-
ver or urine leakage. 
To compare overall complication rates and the severity 
of complications, a standard grading system has been 
adopted. In the field of urology, the Clavien system has 
been applied to radical prostatectomy [14-16] and radical 
cystectomy [17]. Tefekli et al first adopted the modified 
Clavien classification system to stratify complications of 
PCNL in 2007 [18]. In their series of 811 PCNLs, Tefekli 
et al reported overall complications in 29.2% (vs. 33.4% in 
our study) [18]. Grade I, II, IIIa, IIIb, IVa, IVb, and V com-
plications occurred in 4%, 16.3%, 6.6%, 2.8%, 1.1%, 0.3%, 
and 0.1%, respectively. Recently, de la Rosette et al col-
lected prospective data from the Clinical Research Office 
of the Endourological Society (CROES) for 5,803 consec-
utive patients who were treated with PCNL at centers 
around the world during November 2007 through Decem-
ber 2009 [19]. In their report, the distribution of scores in 
the modified Clavien grade was I (11.1%), II (5.3%), IIIa 
(2.3%), IIIb (1.3%), IVa (0.3%), IVb (0.2%), and V (0.03%). 
Staghorn stones were present in 27.5% of patients, com-
pared with 33.8% in our study. In their report, however, the 
number of specific complications in each grade was not 
provided. 
Tefekli et al accounted for the lower incidence of grade 
I complications in their study as being biased by the retro-
spective nature of their study and the omission of certain 
minor complications [18]. In our study, grade I complica-
tions were evident in 14% of patients. The most common 
grade I complication in our study was fever, occurring in 
up to 11% of cases. In a study by Tefekli et al fever accounted 
for 2.8% of complications [18]. They attributed such a low 
incidence of fever to the use of prophylactic antibiotics and 
the separate classification of other complications that may 
cause fever (i.e., blood transfusion, sepsis, etc). We also 
used prophylactic antibiotics in patients with pyuria, but 
did not distinguish transient fever that may have been 
caused by events such as blood transfusion, because that 
may further contribute to selection bias in a retrospective 
study such as ours. In the CROES study, fever of more than 
38.5 degrees occurred in 10.5% of cases, similar to our study 
[19]. In the literature, fever is reported in up to 32% of cases 
after PCNL [20]. Both the AUA and EAU guidelines recom-
mend antibiotic prophylaxis for all patients who are under-
going PCNL [21,22]. The AUA guidelines report the bene-
fits of a single dose of antibiotics. Because we have observed 
death from septic shock, the importance of preoperative an-
tibiotics cannot be emphasized enough.
Grade II complications occurred in 22.3% of our patients, Korean J Urol 2011;52:769-775
774 Shin et al
and most were transient peri-nephrostomy catheter urine 
leakage (15.2%). This complication was managed by simple 
dressing only, but prolonged the hospitalization period 
(5.48±3.31 days vs 4.35±2.38 days, p＜0.05) and therefore 
was classified as a grade II complication, as in the study 
by Tefekli et al [18]. However, transient urine leakage oc-
curred in only 4% of cases in a report by Tefekli [18]. Again, 
the retrospective design of both studies may contribute to 
such differences because such minor complications may 
have been omitted during data collection.
Blood transfusion, the second most common grade II 
complication, was necessary in 6.9% of cases in our study. 
Perhaps the most significant complication of PCNL, bleed-
ing requiring transfusion has been reported to have an in-
cidence as high as 23% [23]. In the CROES study, trans-
fusion was administered in 5.7% of patients [20]. Bleeding 
can occur in every step of PCNL from percutaneous access 
to tract dilation to stone disintegration [24]. This may be 
why in our series, only the mean operation time was found 
to be significant for bleeding requiring transfusion [25]. 
Moreover, 8 patients (1.1%) in our study required se-
lective angioembolization because of uncontrolled bleed-
ing. We could not identify any risk factors in the multi-
variate analysis because of the relatively small number of 
patients. However, El-Nahas et al, in their retrospective 
study of 3,878 PCNLs to identify risk factors for extensive 
post-PCNL hemorrhage requiring selective embolization, 
found that upper calyceal puncture, solitary kidney, stag-
horn stone, multiple punctures, and inexperienced sur-
geon were significant risk factors. The incidence of ex-
tensive post-PCNL hemorrhage was 1% in their study [26]. 
A similar study by Srivastava et al reported that 1.4% of 
patients required angiography or embolization for bleed-
ing control. They concluded that only stone size was a sig-
nificant risk factor [27]. 
In our study, grade IIIb, IVa, IV, and V complications 
were extremely rare, each occurring in less than 1% of 
patients. In fact, the probability of developing a complica-
tion of a grade higher than IIIb in our center was only 2.6% 
(18/698). Two patients had undergone nephrectomy, one 
because of uncontrolled bleeding and the other because of 
xanthogranulomatous pyelonephritis.
The conclusions of this study may be limited by its retro-
spective design. A few variables were missed during data 
collection, and this may have contributed to selection bias. 
Another flaw of this retrospective study is that very few pa-
tients underwent postoperative CT imaging, because of its 
cost-effective nature in the clinical setting. Because our 
definition of success mainly depended on plain X-ray films 
and the need for CT imaging was based mainly on the pa-
tient’s symptoms and laboratory findings, some un-
successful PCNLs may have been misclassified as 
successful. In the literature, these limitations are appa-
rent in most retrospective reports concerning outcomes of 
PCNL. 
Although the modified Clavien classification provides an 
objective, stratified grading system for complications, 
there are some drawbacks. For instance, there is a debate 
over whether to include ancillary treatments as grade 
IIIa/b complication [18]. Furthermore, when comparing 
the complication rate from one center to another, certain 
minor complications such as atelectasis or urine leakage 
may not have been recorded. Therefore, we believe that a 
consensus is needed to specify certain complications that 
should not be omitted. Some may assume that certain com-
plications, especially those classified in lower grades, are 
inherent to general anesthesia or the operation itself. 
Although accurate for obvious complications in higher 
grades, the disparity in lower-grade complications be-
tween centers can be partly explained by this phenomenon.
CONCLUSIONS
The modified Clavien system provides excellent classi-
fication of complications of PCNL stratified by their 
severity. A consensus in describing minor complications 
and in whether to include ancillary treatment, along with 
prospective data collection, may facilitate this classi-
fication becoming the most objective, unified classification 
system yet known. 
The risks of developing clinically significant complica-
tions, such as bowel injury, sepsis, and death, remain low. 
Patients with previous stone-related fever and staghorn 
stone patients are at risk of developing postoperative fever. 
Blood and urine cultures should be obtained in these pa-
tients preoperatively to facilitate targeted antibiotic ther-
apy, especially when sepsis develops. A shorter operation 
time, and thus less manipulation of the pelvocaliceal sys-
tem, is necessary to achieve less bleeding. Therefore, a skil-
led surgical team and proper equipment are imperative.
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